{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T04:40:47Z","timestamp":1760762447577,"version":"build-2065373602"},"reference-count":69,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The neuropeptide calcitonin gene-related peptide (CGRP), especially \u03b1-CGRP, is central in migraine pathophysiology. Although CGRP is a therapeutic target and potential biomarker, inconsistencies in measurement procedures need to be further studied for reliable results. This study aims to analyze factors influencing plasma CGRP measurement. Chronic migraine (CM) patients were recruited in our Headache Unit. Blood samples were collected before and during treatment with CGRP monoclonal antibodies, processed and stored. Levels of CGRP were measured with isoform-specific enzyme-linked immunosorbent assay (ELISA) tests. Statistical tests were used to assess concentration changes and group differences. The addition of protease inhibitors (PIs) to plasma samples significantly increased \u03b1-CGRP level detection, with a smaller effect on \u03b2-CGRP. No correlation was found between the \u03b1- and \u03b2-CGRP levels in plasma. The plasma-PI samples showed higher CGRP concentrations than in serum. The \u03b1-CGRP levels decreased during treatment while the \u03b2-CGRP levels remained stable. \u03b1-CGRP and age correlated negatively, but no sex-related differences were observed either for \u03b1- or \u03b2-CGRP. PI improved CGRP detection in plasma. The \u03b1-CGRP levels, which were influenced by age, decreased with specific treatment, suggesting its potential role as a biomarker. In contrast, \u03b2-CGRP remained stable, suggesting independent regulation of both isoforms.<\/jats:p>","DOI":"10.3390\/ijms26209958","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T16:13:03Z","timestamp":1760717583000},"page":"9958","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma with Added Protease Inhibitors Improves Alpha- and Beta-CGRP Measurement Compared to Serum: Towards a Reliable Biomarker for Chronic Migraine"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2648-6024","authenticated-orcid":false,"given":"Luc\u00eda","family":"de la Guerra-Sasi\u00e1n","sequence":"first","affiliation":[{"name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Hospital Universitario Marqu\u00e9s de Valdecilla & Universidad de Cantabria, 39011 Santander, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"G\u00e1rate","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Hospital Universitario Marqu\u00e9s de Valdecilla & Universidad de Cantabria, 39011 Santander, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Madera","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Hospital Universitario Marqu\u00e9s de Valdecilla & Universidad de Cantabria, 39011 Santander, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4819-636X","authenticated-orcid":false,"given":"Sara","family":"P\u00e9rez-Pereda","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Hospital Universitario Marqu\u00e9s de Valdecilla & Universidad de Cantabria, 39011 Santander, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Pascual-Mato","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Hospital Universitario Marqu\u00e9s de Valdecilla & Universidad de Cantabria, 39011 Santander, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0902-3906","authenticated-orcid":false,"given":"Vicente","family":"Gonz\u00e1lez-Quintanilla","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Hospital Universitario Marqu\u00e9s de Valdecilla & Universidad de Cantabria, 39011 Santander, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Pascual","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Hospital Universitario Marqu\u00e9s de Valdecilla & Universidad de Cantabria, 39011 Santander, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7249-5343","authenticated-orcid":false,"given":"Mar\u00eda","family":"Mu\u00f1oz-San Mart\u00edn","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL), Hospital Universitario Marqu\u00e9s de Valdecilla & Universidad de Cantabria, 39011 Santander, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990\u20132021: A Systematic Analysis for the Global Burden of Disease Study 2021","volume":"23","author":"Steinmetz","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-021-00328-4","article-title":"Migraine","volume":"8","author":"Ferrari","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","first-page":"32","article-title":"Global, Regional, and National Burden and Trends of Migraine among Youths and Young Adults Aged 15\u201339 Years from 1990 to 2021: Findings from the Global Burden of Disease Study 2021","volume":"25","author":"Chen","year":"2024","journal-title":"J. Headache Pain"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10072-020-04643-8","article-title":"Gender-Related Differences in Migraine","volume":"41","author":"Allais","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/jnr.23903","article-title":"Sex-Related Influences in Migraine","volume":"95","author":"Pavlovic","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1474-4422(20)30482-8","article-title":"Menstrual Migraine: A Distinct Disorder Needing Greater Recognition","volume":"20","author":"Vetvik","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1468-2982.2009.01941.x","article-title":"Global Prevalence of Chronic Migraine: A Systematic Review","volume":"30","author":"Natoli","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1526-4610.1999.3903190.x","article-title":"Epidemiology of Chronic Daily Headache in the General Population","volume":"39","author":"Castillo","year":"1999","journal-title":"Headache J. Head Face Pain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41588-021-00990-0","article-title":"Genome-Wide Analysis of 102,084 Migraine Cases Identifies 123 Risk Loci and Subtype-Specific Risk Alleles","volume":"54","author":"Hautakangas","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/03331024221145962","article-title":"Migraine Genetics: Status and Road Forward","volume":"43","author":"Harder","year":"2023","journal-title":"Cephalalgia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","article-title":"Migraine and the Trigeminovascular System\u201440 Years and Counting","volume":"18","author":"Ashina","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/0333102420974359","article-title":"How Does the Brain Change in Chronic Migraine? Developing Disease Biomarkers","volume":"41","author":"Coppola","year":"2021","journal-title":"Cephalalgia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive Peptide Release in the Extracerebral of Humans During Migraine Headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410230214","article-title":"Ekman Release of Vasoactive Peptides in the Extracerebral Circulation of Humans and the Cat During Activation of the Trigeminovascular System","volume":"23","author":"Goadsby","year":"1988","journal-title":"Ann. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","article-title":"CGRP Physiology, Pharmacology, and Therapeutic Targets: Migraine and Beyond","volume":"103","author":"Russo","year":"2023","journal-title":"Physiol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11916-017-0618-8","article-title":"Neuropeptides as a Marker for Chronic Headache","volume":"21","author":"Riesco","year":"2017","journal-title":"Curr. Pain. Headache Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0306-4522(88)90018-8","article-title":"Differential Expression of \u2c6d-CGRP and B-CGRP by Primary Sensory Neurons and Enteric Autonomic Neurons of the Rat","volume":"25","author":"Mulderry","year":"1988","journal-title":"Neuroscience"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin Gene-Related Peptide: Physiology and Pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/298240a0","article-title":"Alternative RNA Processing in Calcitonin Gene Expression Generates MRNAs Encoding Different Polypeptide Products","volume":"298","author":"Amara","year":"1982","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/j.pain.0000000000000831","article-title":"The Role of Calcitonin Gene-Related Peptide in Peripheral and Central Pain Mechanisms Including Migraine","volume":"158","author":"Iyengar","year":"2017","journal-title":"Pain"},{"key":"ref_21","first-page":"390","article-title":"Calcitonin Gene\u2013Related Peptide in Migraine: From Pathophysiology to Treatment","volume":"37","author":"Cuadrado","year":"2022","journal-title":"Neurologia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/08990229209144762","article-title":"Calcitonin Supplying the Gene-Related Peptide-Containing Rat Digestive System: Differential and Expression Pattern Neurons Distribution","volume":"9","author":"Sternini","year":"1992","journal-title":"Somatosens. Mot. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"G\u00e1rate, G., Polanco, M., Madera, J., Mu\u00f1oz-San Mart\u00edn, M., Pascual-Mato, M., Gonz\u00e1lez-Quintanilla, V., and Pascual, J. (2025). Influence of Constipation in the Behavior of Circulating Alpha- and Beta-CGRP Levels in Chronic\/High-Frequency Migraine Patients After CGRP Monoclonal Antibodies. Biomedicines, 13.","DOI":"10.3390\/biomedicines13051254"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/head.14768","article-title":"Differences in Circulating Alpha-Calcitonin Gene-Related Peptide Levels in Inflammatory Bowel Disease and Its Relation to Migraine Comorbidity: A Cross-Sectional Study","volume":"64","author":"Castro","year":"2024","journal-title":"Headache J. Head Face"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mcn.2010.10.005","article-title":"Cerebellar Distribution of Calcitonin Gene-Related Peptide (CGRP) and Its Receptor Components Calcitonin Receptor-like Receptor (CLR) and Receptor Activity Modifying Protein 1 (RAMP1) in Rat","volume":"46","author":"Edvinsson","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s10194-024-01945-6","article-title":"Differentially Localizing Isoforms of the Migraine Component Calcitonin Gene-Related Peptide (CGRP), in the Mouse Trigeminal Ganglion: \u0392CGRP Is Translated but, Unlike ACGRP, Not Sorted into Axons","volume":"26","author":"Haanes","year":"2025","journal-title":"J. Headache Pain"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuroscience.2010.05.016","article-title":"Differential Distribution of Calcitonin Gene-Related Peptide and Its Receptor Components in the Human Trigeminal Ganglion","volume":"169","author":"Eftekhari","year":"2010","journal-title":"Neuroscience"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jpain.2013.03.010","article-title":"Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System","volume":"14","author":"Eftekhari","year":"2013","journal-title":"J. Pain"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the Target of New Migraine Therapies\u2014Successful Translation from Bench to Clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1007\/s00415-023-11706-1","article-title":"Migraine: From Pathophysiology to Treatment","volume":"270","author":"Puledda","year":"2023","journal-title":"J. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/13543784.2019.1618830","article-title":"Gepants for the Treatment of Migraine","volume":"28","author":"Negro","year":"2019","journal-title":"Expert. Opin. Investig. Drugs."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/head.13211","article-title":"CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study","volume":"58","author":"Sobrino","year":"2018","journal-title":"Headache J. Head Face Pain"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ana.26472","article-title":"Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine","volume":"92","author":"Alpuente","year":"2022","journal-title":"Ann. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.26658","article-title":"Serum Alpha and Beta-CGRP Levels in Chronic Migraine Patients Before and After Monoclonal Antibodies Against CGRP or Its Receptor","volume":"94","author":"Pascual","year":"2023","journal-title":"Ann. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1212\/WNL.0b013e3182a6cb72","article-title":"Interictal Increase of CGRP Levels in Peripheral Blood as a Biomarker for Chronic Migraine","volume":"81","author":"Larrosa","year":"2013","journal-title":"Neurology"},{"key":"ref_36","first-page":"1","article-title":"Serum CGRP in Migraine Patients Using Erenumab as Preventive Treatment","volume":"23","author":"Garrelds","year":"2022","journal-title":"J. Headache Pain"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/j.pain.0000000000000119","article-title":"OnabotulinumtoxinA Decreases Interictal CGRP Plasma Levels in Patients with Chronic Migraine","volume":"156","author":"Larrosa","year":"2015","journal-title":"Pain"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11033-025-10542-y","article-title":"Unraveling the Role of CGRP in Neurological Diseases: A Comprehensive Exploration to Pathological Mechanisms and Therapeutic Implications","volume":"52","author":"Sarkar","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.arcmed.2022.12.002","article-title":"Serum Calcitonin Gene-Related Peptide \u03b1 and \u03b2 Levels Are Increased in COVID-19 Inpatients","volume":"54","author":"Pascual","year":"2023","journal-title":"Arch. Med. Res."},{"key":"ref_40","first-page":"1","article-title":"Unravelling the Role of Beta-CGRP in Inflammatory Bowel Disease and Its Potential Role in Gastrointestinal Homeostasis","volume":"24","author":"Castro","year":"2024","journal-title":"BMC Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0333102415625614","article-title":"Migraine Biomarkers in Cerebrospinal Fluid: A Systematic Review and Meta-Analysis","volume":"37","author":"Zielman","year":"2017","journal-title":"Cephalalgia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s10194-024-01769-4","article-title":"Untangling the Mess of CGRP Levels as a Migraine Biomarker: An in-Depth Literature Review and Analysis of Our Experimental Experience","volume":"25","author":"Pascual","year":"2024","journal-title":"J. Headache Pain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/head.13802","article-title":"Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis","volume":"60","author":"Frederiksen","year":"2020","journal-title":"Headache J. Head Face Pain"},{"key":"ref_44","first-page":"64775","article-title":"Detection and Quantification of Calcitonin Gene-Related Peptide (CGRP) in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay","volume":"2023","author":"Krishnan","year":"2023","journal-title":"J. Vis. Exp."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8523","DOI":"10.1073\/pnas.1203195109","article-title":"Peptidomics Approach to Elucidate the Proteolytic Regulation of Bioactive Peptides","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Kumar, A., Potts, J.D., and DiPette, D.J. (2019). Protective Role of \u03b1-Calcitonin Gene-Related Peptide in Cardiovascular Diseases. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.00821"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1177\/03331024211024161","article-title":"CGRP Measurements in Human Plasma\u2014A Methodological Study","volume":"41","author":"Messlinger","year":"2021","journal-title":"Cephalalgia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.peptides.2007.05.002","article-title":"Intravenous Infusion of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in a Patient with Multiple Myeloma and Myeloma Kidney: A Case Study","volume":"28","author":"Li","year":"2007","journal-title":"Peptides"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gut.19.11.1049","article-title":"Vasoactive Intestinal Peptide in Man: Pharmacokinetics, Metabolic and Circulatory Effects","volume":"19","author":"Domschke","year":"1978","journal-title":"Gut"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0167-0115(85)90013-8","article-title":"Infusion of a Novel Peptide, Calcitonin Gene-Related Peptide (CGRP) in Man. Pharmacokinetics and Effects on Gastric Acid Secretion and on Gastrointestinal Hormones","volume":"10","author":"Kraenzlin","year":"1985","journal-title":"Regul. Pept."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3959(00)00232-3","article-title":"Evidence for Increased Plasma Levels of Calcitonin Gene-Related Peptide in Migraine Outside of Attacks","volume":"86","author":"Ashina","year":"2000","journal-title":"Pain"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","article-title":"Chronic Migraine: Risk Factors, Mechanisms and Treatment","volume":"12","author":"May","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Amiri, P., Kazeminasab, S., Nejadghaderi, S.A., Mohammadinasab, R., Pourfathi, H., Araj-Khodaei, M., Sullman, M.J.M., Kolahi, A.A., and Safiri, S. (2022). Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.800605"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Nahvi, R.J., and Sabban, E.L. (2020). Sex Differences in the Neuropeptide Y System and Implications for Stress Related Disorders. Biomolecules, 10.","DOI":"10.3390\/biom10091248"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7424399","DOI":"10.1155\/2020\/7903140","article-title":"Higher Serum Neuropeptide y Levels Are Associated with Metabolically Unhealthy Obesity in Obese Chinese Adults: A Cross-Sectional Study","volume":"2020","author":"Tang","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/acn3.51704","article-title":"Associations of SNfL with Clinico-Radiological Measures in a Large MS Population","volume":"10","author":"Sotirchos","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Garelja, M.L., Rees, T.A., and Hay, D.L. (2025). Calcitonin Gene-related Peptide and Headache: Comparison of Two Commonly Used Assay Kits Highlights the Perils of Measuring Neuropeptides with Enzyme-linked Immunosorbent Assays. Headache J. Head Face Pain, 1\u201310.","DOI":"10.1111\/head.15011"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pain.2006.09.017","article-title":"Increased Plasma Substance P and CGRP Levels, and High ACE Activity in Migraineurs during Headache-Free Periods","volume":"128","author":"Fusayasu","year":"2007","journal-title":"Pain"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0b013e31826170ce","article-title":"Endothelial Progenitor Cells: A New Key for Endothelial Dysfunction in Migraine","volume":"79","author":"Sobrino","year":"2012","journal-title":"Neurology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1177\/0333102419856640","article-title":"Calcitonin Gene-Related Peptide Levels in Tear Fluid Are Elevated in Migraine Patients Compared to Healthy Controls","volume":"39","author":"Kamm","year":"2019","journal-title":"Cephalalgia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10194-024-01772-9","article-title":"Dynamic Fluctuations of Salivary CGRP Levels during Migraine Attacks: Association with Clinical Variables and Phenotypic Characterization","volume":"25","author":"Alpuente","year":"2024","journal-title":"J. Headache Pain"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1468-2982.2003.00552.x","article-title":"Glutamate and Nitric Oxide Pathway in Chronic Daily Headache: Evidence from Cerebrospinal Fluid","volume":"23","author":"Gallai","year":"2003","journal-title":"Cephalgia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.20605","article-title":"No Increase of Calcitonin Gene-Related Peptide in Jugular Blood during Migraine","volume":"58","author":"Tvedskov","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0304-3959(99)00159-1","article-title":"Plasma Levels of Substance P, Neuropeptide Y and Vasoactive Intestinal Polypeptide in Patients with Chronic Tension-Type Headache","volume":"83","author":"Ashina","year":"1999","journal-title":"Pain"},{"key":"ref_65","unstructured":"(2025, May 26). Merck Protease Inhibitor Cocktail Powder (PI). Available online: https:\/\/www.sigmaaldrich.com\/ES\/es\/product\/sigma\/p2714."},{"key":"ref_66","unstructured":"Abbexa Ltd (2025, May 12). ELISA Kit for \u03b1-CGRP. Available online: https:\/\/www.abbexa.com\/calcitonin-gene-related-peptide-elisa-kit-1?srsltid=AfmBOordfUMK6-UJ9E1A5FLKW8g3ERFymJHI-glpvRdcS08abgL5HUk8."},{"key":"ref_67","unstructured":"Wuhan Huamei Biotech Co., Ltd (2025, May 12). ELISA Kit for \u03b2-CGRP. Available online: https:\/\/www.cusabio.com\/ELISA-Kit\/Human-calcitonin-gene-related-peptideCGRP-ELISA-Kit-70882.html."},{"key":"ref_68","unstructured":"Arigo Biolaboratories Corp (2025, May 12). Arigo\u2019s Elisa Calculator. Available online: https:\/\/www.arigobio.com\/elisa-calculator."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1007\/s10620-022-07473-0","article-title":"Increase in Serum Calcitonin Gene-Related Peptide \u03b2 (CGRP\u03b2) Levels in COVID-19 Patients with Diarrhea: An Underlying Mechanism?","volume":"67","author":"Pascual","year":"2022","journal-title":"Dig. Dis. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/20\/9958\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T04:23:11Z","timestamp":1760761391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/20\/9958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":69,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["ijms26209958"],"URL":"https:\/\/doi.org\/10.3390\/ijms26209958","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}